Cliff Douglas reflects on his evolving stance on reduced-risk nicotine products, acknowledging his initial opposition and highlighting the need for science-based strategies to help people who smoke switch to safer alternatives.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Read our Privacy Policy
